Dissecting the Role of RNA Pol II Pausing in Early Mammalian Development
Dissecting the Role of RNA Pol II Pausing in Early Mammalian Development
批准号:
10386826
负责人:
Abderhman Anees Abuhashem
金额:
$4.9万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-04-01 至 2025-03-31
关键词:
AcuteAffectAutomobile DrivingBiologicalCell LineCell physiologyCellsDNA Polymerase IIDataDevelopmentDiseaseEmbryoEmbryonic DevelopmentEnsureEpiblastExtracellular Signal Regulated KinasesFailureFibroblast Growth FactorGene Expression RegulationGenesGenetic TranscriptionGoalsIn VitroKnock-outLinkLong-Term EffectsMalignant NeoplasmsMeasuresMethodsMolecularMusNuclearOutcomePathway interactionsPhenotypePlayPrevalenceProcessProtocols documentationPublishingRNARNA Polymerase IIRegulationResistanceRoleRunningSignal PathwaySignal TransductionSignal Transduction PathwayTechniquesTestingTherapeuticTranscription ProcessTranscriptional ActivationTranscriptional RegulationWorkbasecell typedevelopmental diseasedirected differentiationembryonic stem cellextracellulargastrulationimplantationin vivoinsightmouse developmentnegative elongation factornovelpluripotencypreimplantationpromoterquantitative imagingresponsestemtemporal measurementtherapeutic targettranscriptome sequencingtranscriptomics
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
Transcription regulation underlies the diversity of cell types and functions. The process of transcription itself
has multiple steps that may be regulated separately. Promoter-proximal RNA Pol II pausing has recently been
described as a widespread rate-limiting step of transcription and a possible point of gene regulation. Studies
disrupting the critical pausing factor Negative elongation factor-B (Nelf-b) in mouse and mouse embryonic stem
cells (mES) highlighted its essential role in development and a cross-talk with FGF/ERK signaling transduction.
However, it is unclear what role pausing plays in mammalian development. Furthermore, it is unclear how
pausing may affect specific targets of FGF/ERK signaling, and whether this cross-talk is relevant in vivo.
The long-term goal of this proposal is to establish a molecular understanding of how gene regulation can be
achieved at the level of promoter-proximal pausing during transcription. The objective of the present proposal is
to mechanistically determine the role of pausing during epiblast pluripotency transitions in early mammalian
development. This objective will be achieved by a detailed phenotypic and transcriptomic analysis of Nelf-b-/-
embryos at several early developmental stages to analyze pluripotency transitions (Aim 1). To expand on these
results and interrogate pausing at a high molecular and temporal resolution, a Nelf-b-degron mES cell line has
been established to test the immediate and direct effects of pausing-loss in mES cells under different signaling
conditions. I will utilize nascent RNA-seq techniques and directed differentiation approaches to build a
mechanistic link between pausing, FGF/ERK transcriptional activation, and pluripotency transitions in embryos
and mES cells (Aim 2). My central hypothesis is that pausing is required for epiblast pluripotency
transitions in mouse development via direct regulation of FGF/ERK transcriptional targets.
The expected outcome of this project is to uncover the mechanistic link between pausing and signal
transduction, explain the role of pausing in mammalian development. It promises to yield novel insights into gene
regulation at the pausing level. The link between pausing and signaling is of high importance to other biological
contexts considering the prevalence of pausing and necessity of signal transduction to perform fundamental
cellular functions beyond responses to FGF/ERK in development. Furthermore, given that FGF/ERK signaling
is amongst the top dysregulated pathways in developmental diseases and malignancies, insights into the
molecular mechanisms of this pathway will yield novel insights to therapeutically target it.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Dissecting the Role of RNA Pol II Pausing in Early Mammalian Development
-
批准号:10611302
-
项目类别:
-
资助金额:$5.27万
-
财政年份:2021
-
负责人:Abderhman Anees Abuhashem
-
依托单位:
海外基金